Literature DB >> 31708713

Pheochromocytoma: Another Neuroendocrine Tumor that Substantially Affects the Heart.

Run Yu1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31708713      PMCID： PMC6827478          DOI： 10.14503/THIJ-19-7024

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  6 in total

Review 1.  Perioperative management of pheochromocytoma: the heart of the issue.

Authors:  J Shen; R Yu
Journal:  Minerva Endocrinol       Date:  2013-03       Impact factor: 2.184

Review 2.  Carcinoid Heart Disease: Review of Current Knowledge.

Authors:  Pradhum Ram; Jorge L Penalver; Kevin Bryan U Lo; Janani Rangaswami; Gregg S Pressman
Journal:  Tex Heart Inst J       Date:  2019-02-01

3.  Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma.

Authors:  Alessandra Giavarini; Antoine Chedid; Guillaume Bobrie; Pierre-François Plouin; Albert Hagège; Laurence Amar
Journal:  Heart       Date:  2013-07-09       Impact factor: 5.994

4.  Cardiac complications as initial manifestation of pheochromocytoma: frequency, outcome, and predictors.

Authors:  Run Yu; Nicholas N Nissen; Serguei I Bannykh
Journal:  Endocr Pract       Date:  2012 Jul-Aug       Impact factor: 3.443

5.  Is the excess cardiovascular morbidity in pheochromocytoma related to blood pressure or to catecholamines?

Authors:  Roeland F Stolk; Carel Bakx; Jan Mulder; Henri J L M Timmers; Jacques W M Lenders
Journal:  J Clin Endocrinol Metab       Date:  2013-02-13       Impact factor: 5.958

6.  Pheochromocytoma and stress cardiomyopathy: Insight into pathogenesis.

Authors:  Sahil Agrawal; Jamshid Shirani; Lohit Garg; Amitoj Singh; Santo Longo; Angelita Longo; Mark Fegley; Lauren Stone; Muhammad Razavi; Nicoleta Radoianu; Sudip Nanda
Journal:  World J Cardiol       Date:  2017-03-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.